Department of Obstetrics and Gynecology, Mardin Women's and Children's Hospital, Mardin, Turkey.
Gynecol Obstet Invest. 2011;71(1):32-40. doi: 10.1159/000320725. Epub 2010 Dec 15.
To compare the efficacy and safety of sustained-release dinoprostone vaginal pessary and concurrent high-dose oxytocin infusion with sustained-release dinoprostone vaginal pessary followed 6 h later by high-dose oxytocin infusion for cervical ripening and labor induction.
A total of 500 nulliparous or multiparous women with a singleton pregnancy, Bishop score ≤4 and admitted for labor induction. Women were randomly assigned to induction of labor using intravaginal dinoprostone with concurrent high-dose oxytocin (n = 250) or intravaginal dinoprostone pessary followed 6 h later by high-dose oxytocin (n = 250). The primary outcome was the number of vaginal deliveries achieved within 24 h of labor induction.
Baseline characteristics of both groups were comparable. Vaginal delivery within 24 h of labor induction was significantly increased with sustained-release dinoprostone followed 6 h later by high-dose oxytocin infusion (92.8 vs. 82.0%, RR 2.82, 95% CI 1.58-5.04). There were more cesarean section deliveries in the dinoprostone with concurrent high-dose oxytocin group (16.8 vs. 6.8%, RR 0.36, 95% CI 0.20-0.65). Maternal outcomes did not differ significantly. An Apgar score of <7 at 5 min was found more often in the dinoprostone with concurrent high-dose oxytocin group (3.6%) in comparison to dinoprostone pessary followed 6 h later by high-dose oxytocin (0.8%), although this was not statistically different (RR 0.21, 95% CI 0.04-1.01).
Sustained-release dinoprostone followed 6 h later by high-dose oxytocin infusion appears to be safer and more effective than sustained-release dinoprostone with concurrent high-dose oxytocin infusion in achieving cervical ripening and successful vaginal delivery.
比较持续性地诺前列酮阴道栓剂与同期高剂量催产素输注,以及持续性地诺前列酮阴道栓剂 6 小时后再给予高剂量催产素输注在宫颈成熟和引产中的疗效和安全性。
共纳入 500 例单胎妊娠、初产妇或经产妇、Bishop 评分≤4 分、因引产入院的患者。患者随机分为两组,一组采用阴道内给予地诺前列酮联合同期高剂量催产素(n = 250),另一组采用阴道内给予地诺前列酮栓剂,6 小时后再给予高剂量催产素(n = 250)。主要结局为引产 24 小时内阴道分娩的例数。
两组的基线特征相当。持续性地诺前列酮 6 小时后再给予高剂量催产素输注组的引产 24 小时内阴道分娩的比例显著增加(92.8% vs. 82.0%,RR 2.82,95%CI 1.58-5.04)。同期给予地诺前列酮和高剂量催产素组的剖宫产分娩例数更多(16.8% vs. 6.8%,RR 0.36,95%CI 0.20-0.65)。两组产妇结局无显著差异。同期给予地诺前列酮和高剂量催产素组的新生儿 5 分钟 Apgar 评分<7 分的比例(3.6%)高于持续性地诺前列酮 6 小时后再给予高剂量催产素组(0.8%),但差异无统计学意义(RR 0.21,95%CI 0.04-1.01)。
与持续性地诺前列酮与同期高剂量催产素输注相比,持续性地诺前列酮 6 小时后再给予高剂量催产素输注似乎更安全,且在促进宫颈成熟和阴道分娩成功方面更有效。